The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bicycle Therapeutics Plc ADR shares valued at $1,724 were sold by Young Alethia on Apr 02 ’25. At $8.02 per share, Young Alethia sold 215 shares. The insider’s holdings dropped to 45,390 shares worth approximately $0.34 million following the completion of this transaction.
Also, Skynner Michael sold 1,038 shares, netting a total of over 7,764 in proceeds. Following the sale of shares at $7.48 each, the insider now holds 121,870 shares.
Before that, Skynner Michael had sold 814 shares from its account. In a trade valued at $6,528, the CHIEF TECHNOLOGY OFFICER traded Bicycle Therapeutics Plc ADR shares for $8.02 each. Upon closing the transaction, the insider’s holdings decreased to 814 shares, worth approximately $0.91 million.
As published in their initiating research note from Stephens on November 08, 2024, Bicycle Therapeutics Plc ADR [BCYC] has been an Equal-weight and the price target has been revised to $25. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early September. As of August 07, 2024, B. Riley Securities has decreased its “Buy” rating to a “Neutral” for BCYC. Earlier on September 11, 2023, B. Riley Securities upgraded its rating. Their new recommendation was “a Buy” for BCYC stock which previously was a “a Neutral”.
Analyzing BCYC Stock Performance
During the last five days, there has been a surge of approximately 13.17%. Over the course of the year, Bicycle Therapeutics Plc ADR shares have dropped approximately -47.21%. Shares of the company reached a 52-week high of $15.47 on 01/07/25 and a 52-week low of $6.10 on 04/09/25. A 50-day SMA is recorded $9.71, while a 200-day SMA reached $18.14.
Support And Resistance Levels for Bicycle Therapeutics Plc ADR (BCYC)
According to the 24-hour chart, there is a support level at 7.29, which, if violated, would cause prices to drop to 7.19. In the upper region, resistance lies at 7.49. The next price resistance is at 7.60. RSI (Relative Strength Index) is 40.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.29, which suggests the price will decrease in the coming days. Percent R is at 53.93%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
